IMMUNE-MEDIATED RENAL DISORDER

This adverse event was reported 414 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED RENAL DISORDER:

# Drug Count
0 PEMBROLIZUMAB 257
1 NIVOLUMAB 102
2 CARBOPLATIN 73
3 IPILIMUMAB 57
4 PACLITAXEL 46
5 PACLITAXEL (AIBUMIN-BOUND) 39
6 CISPLATIN 37
7 PEMETREXED DISODIUM 35
8 FLUOROURACIL 25
9 FLUOROURACIL CREAM, 0.5% 25
See all common drugs associated with IMMUNE-MEDIATED RENAL DISORDER

IMMUNE-MEDIATED RENAL DISORDER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEMBROLIZUMAB 257 0.0024
1 PLATINUM 1 0.0019
2 TREMELIMUMAB 8 0.0018
3 NALDEMEDINE 3 0.0018
4 CEMIPLIMAB-RWLC 3 0.0014
5 IPILIMUMAB 57 0.0013
6 ENFORTUMAB VEDOTIN 10 0.0013
7 SENNOSIDES A AND B 2 0.0012
8 PEMIGATINIB 1 0.0012
9 LEVOLEUCOVORIN 4 0.0010
See all drugs enriched for association with IMMUNE-MEDIATED RENAL DISORDER